Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation

NCT03706833 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT03706833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03706833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 30, 2018
Completion date
June 30, 2031
Enrollment
1,247 (estimated)
Sites
81

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative mitral valve disease, functional mitral regurgitation, mitral insufficiency, mitral regurgitation